Comparing two drugs carbetocin and oxytocin in prevention of postpartum hemorrhage in a randomly selected deliveries in mother hospital. Oxytocin is routinely used drug instead of which we are using carbetocin also in selected patients and comparing their efficacies

To compare efficacy of carbetocin vs oxytocin in prevention of postpartum hemorrhage-a randomised control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047176

Enrollment

220

Registered

2022-11-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Efficacy of carbetocin prevention of PPH: Carbetocin is synthetic analogue of oxytocin(commonly used drug in prevention of PPH) which is heat stable and given as single dose. Control In

Eligibility

Inclusion criteria

Inclusion criteria: -SINGLETON PREGNANCIES -UNCOMPLICATED -TERM(37-42wks) -SPONTANEOUS OR INDUSED -LSCS OR VAGINAL DELIVERIES

Exclusion criteria

Exclusion criteria: -H/O PPH -RISK FACTORS FOR PPH -UTERINE OVERDISTENSION AS IN TWINS, POLYHYDRAMNIOS, FETAL MACROSOMIA -MATERNAL COMPLICATIONS LIKE HEART DISEASE, EPILEPSY -GENERAL ANESTHESIA -APH

Design outcomes

Primary

Measure	Time frame
To compare efficacy of oxytocin vs carbetocin in prevention of PPH by comparing need of additional uterotonics among both drugsTimepoint: Within 24 hours	—

Secondary

Measure	Time frame
To compare amount of blood loss and Hb deficit among both drugsTimepoint: Within 24 hrs of delivery	—

Countries

India

Contacts

Public ContactDr Bindhu Varghese

Mother hospital

binduthom@yahoo.com8921142140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026